# reload+after+2024-01-23 00:46:02.088660
address1§855 North Wolfe Street
address2§Suite 601
city§Baltimore
state§MD
zip§21205
country§United States
phone§737-289-0835
website§https://mirapharmaceuticals.com
industry§Drug Manufacturers—General
sector§Healthcare
longBusinessSummary§MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Adam  Kaplin M.D., Ph.D.', 'age': 56, 'title': 'Co-Founder, President & Chief Science Officer', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 50000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Christopher C. Chapman Jr., M.D.', 'age': 70, 'title': 'Executive Chairman', 'yearBorn': 1953, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Erez  Aminov', 'age': 45, 'title': 'CEO & Director', 'yearBorn': 1978, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Michelle  Yanez M.B.A.', 'age': 51, 'title': 'CFO, Secretary & Treasurer', 'yearBorn': 1972, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Christos  Nicholoudis Esq.', 'age': 33, 'title': 'General Counsel & Director', 'yearBorn': 1990, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
currency§USD
dateShortInterest§1702598400
forwardEps§-0.52
exchange§NCM
quoteType§EQUITY
shortName§MIRA Pharmaceuticals, Inc.
longName§MIRA Pharmaceuticals, Inc.
firstTradeDateEpochUtc§1692019800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§a71f8b50-3996-3ccd-98e2-c993481fee2f
gmtOffSetMilliseconds§-18000000
targetHighPrice§22.7
targetLowPrice§22.7
targetMeanPrice§22.7
targetMedianPrice§22.7
recommendationKey§none
numberOfAnalystOpinions§1
quickRatio§6.758
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
